Clinical Trial Update: An Open-Label, Single-Arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of CD20 Monoclonal Antibody Combined With NK042 Cell Injection in the Treatment of Multiple Sclerosis (MS). [EARLY_Phase 1]

View source ↗

Summary

An open-label, single-arm early Phase 1 trial evaluating the safety and preliminary efficacy of a CD20 monoclonal antibody combined with NK042 cell injections f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• CD20 monoclonal antibody
• NK042 cell injection (NK042)

Snippet

Sponsor: The Affiliated Hospital of Xuzhou Medical University | Conditions: Multiple Sclerosis | EARLY_Phase 1 | Status: NOT_YET_RECRUITING